Allergan Reaches Tentative $2.37 Billion Deal to Settle Opioid Suitsnews2022-07-29T17:08:24+00:00July 29th, 2022|The New York Times|
Teva Reaches Tentative $4.25 Billion Settlement Over Opioidsnews2022-07-26T22:26:32+00:00July 26th, 2022|The New York Times|
Abortion Pills Take the Spotlight as States Impose Abortion Bansnews2022-06-26T07:00:11+00:00June 26th, 2022|The New York Times|
Trial of New Alzheimer’s Drug Reports Disappointing Resultsnews2022-06-16T22:25:55+00:00June 16th, 2022|The New York Times|
Un fármaco para la alopecia recibe aprobación de la FDAnews2022-06-14T19:39:55+00:00June 14th, 2022|The New York Times|
New Experimental Therapy for A.L.S. Approved in Canadanews2022-06-14T00:10:45+00:00June 14th, 2022|The New York Times|
F.D.A. Approves Alopecia Drug That Restores Hair Growth in Many Patientsnews2022-06-13T21:35:59+00:00June 13th, 2022|The New York Times|
Ivermectin Has Little Effect on Recovery Time From Covid, Study Findsnews2022-06-13T02:53:08+00:00June 13th, 2022|The New York Times|
21 Americans Infected With Monkeypox, C.D.C. Reportsnews2022-06-03T18:56:29+00:00June 3rd, 2022|The New York Times|